Teva Launches Generic Cozaar/Hyzaar With Market Exclusivity As FDA Seeks Court Action To Permit Other Entrants

Teva's skirmish with FDA has paid off. The company launched generic versions of Merck's top-selling hypertension drugs Cozaar (losartan) and Hyzaar (losartan/hydrochlorothiazide) on April 6 with 180 days of marketing exclusivity